Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 1000 patients treated with the DETOUR™ System.

See Release

All News

Archives

Endologix Announces 1000 patients treated with the DETOUR™ System.

Endologix Appoints Andrew Davis as Chief Commercial Officer

Endologix Announces Leadership Transition

Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session

Endologix Appoints Graham Phillips as Chief Operating Officer